We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > Articles > Testing > Content Piece

The FDA Wants the Public’s Data on Vaping-related Lung Injuries

By Leo Bear-McGuinness

Published: Feb 18, 2020   
Listen with
Register for FREE to listen to this article
Thank you. Listen to this article using the player above.

The US Food and Drug Administration (FDA) is seeking public comments related to e-cigarette, or vaping, product use-associated lung injuries (EVALI).

To bolster its investigation into the recent EVALI outbreak, the administration is looking for unpublished reports or information on the specific chemicals, compounds, and ingredients of suspected vaping products.

Calling all vapers

Like an epidemic outbreak, the vaping crisis burst across the US at the tail-end of the summer of 2019. By September 13, 6 people had died and 380 were suffering from lung injuries. Three months later, the tally stood at 48 dead and 2,291 injured.

Before long, vitamin E acetate, a thickening agent commonly used in the illicit vaping market, became the chief chemical suspect. And following the FDA’s own tests, the agency has confirmed that the acetate substance is “strongly linked to the EVALI outbreak.”

“National and state data from patient reports and product sample testing suggest vaping products containing tetrahydrocannabinol [THC], particularly from informal sources like friends, or family, or in-person or online dealers, are linked to most cases and play a major role, and that the presence of the compound vitamin E acetate in vaping products is strongly linked to the outbreak,” Stephen Hahn, the FDA’s commissioner, said in a statement.

Fortunately, the EVALI crisis seems to be abating. The proportion of hospitalized EVALI patients reported to the Centers for Disease Control and Prevention (CDC) declined from 58 percent on November 12, 2019, to 30 percent on December 3.

Now, to help prevent any future outbreak, the FDA has opened up a comment period that will last until April 20, 2020. Any member of the public with relevant data that aren’t available in published scientific literature can submit their findings either electronically or via post.

“As part of our efforts to mitigate and prevent a potential future outbreak of vaping injuries, we are asking the public for input on additional steps the FDA can take to inform our regulatory work and address the illegal modification of these products,” Hahn continued.

Vaping bad

As of January 14, 2020, the CDC has found that 82 percent of patients admitted to hospital with EVALI reported using THC-containing products. A recent paper, authored by members of the FDA’s Forensic Chemistry Center, also discovered that THC and vitamin E acetate compounds can become linked with hydrogen bonds in e-cigarette liquids and aerosol.

But this close association between EVALI and THC shouldn’t be conflated with a direct cause, analysts warn.

“It's not the THC that's making people sick, and I think that's a really important distinction to make,” Dr Swetha Kaul, vice president of the board Of directors at the California Cannabis Industry Association, told Analytical Cannabis last October.

Despite being the largest legal cannabis market in the world, California has been struggling against an indomitable illicit marijuana trade. In 2019, it’s estimated that $8.7 billion of the total $12 billion made in cannabis sales went to the illegal market.

“Vitamin E acetate is very heavily used in the illegal vaping market; 20, 30, 60 percent of a cartridge could be vitamin E acetate,” Kaul continued.

“The safer option is to shop [for] legal, tested products. I feel like that's the messaging that might resonate,” she said. “Because if you just tell people to stop vaping, they're just going to ignore the entire message. So how about giving them a route where at least their chances of staying safe are higher and better?”

Leo Bear-McGuinness

Science Writer & Editor

Leo joined Analytical Cannabis in 2019. From research to regulations and analysis to agriculture, his writing covers all the need-to-know news for the cannabis industry. He holds a Bachelor's in Biology from Newcastle University and a Master's in Science Communication from the University of Edinburgh.


Like what you just read? You can find similar content on the topic tags shown below.

Policy Testing

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter